Open access · CC-BY
via OpenAlex
The Ambiguous Role of HMGB1 Across the Hallmarks of Aging: A Narrative Review
Manru Ning, Yihuai Liang, Liu Zhang, Feifei Wang, Li He
Clinical Interventions in Aging · 2025 · ▲ 2 citations
Genomic instability
Telomere attrition
Epigenetic alterations
Loss of proteostasis
Deregulated nutrient-sensing
Mitochondrial dysfunction
Cellular senescence
Altered intercellular communication
Chronic inflammation
Human
Preclinical / animal
Review
Abstract
Aging is a complex, multifactorial process driven by interconnected biological mechanisms collectively known as the telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition), which contribute to functional decline and the onset of age-related diseases. High-mobility group box 1 (HMGB1), a nuclear DNA chaperone and damage-associated molecular pattern (DAMP), plays a pivotal role in regulating these hallmarks through its dual functions: preserving genomic stability within the nucleus and promoting inflammatory responses when released extracellularly. This review examines the multifaceted involvement of HMGB1 in key aging hallmarks, such as genomic instability, telomere attrition, mitochondrial dysfunction(definition), and chronic inflammation among others. Preclinical studies demonstrate that nuclear HMGB1 supports chromatin integrity and DNA repair, whereas its extracellular release triggers TLR4/RAGE signaling pathways, thereby intensifying inflammaging(definition) and senescence-associated secretory phenotypes (SASP). Emerging therapeutic approaches-such as HMGB1 inhibitors, neutralizing antibodies, and epigenetic modulators-show potential in restoring genomic homeostasis and mitigating age-related pathologies. Nevertheless, significant challenges remain, including elucidating HMGB1's roles in nutrient sensing and psychosocial stress, fine-tuning interventions to preserve its nuclear functions while minimizing extracellular toxicity, and establishing efficacy in human clinical settings. Addressing these gaps may position HMGB1 as a promising multifunctional target for delaying aging and translating preclinical findings into clinical applications.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2147/cia.s550572
- Canonical
- link ↗
- Fetched
- 2026-06-01 MST
Cite this
APA
Ning, M., Liang, Y., Zhang, L., Wang, F., & He, L. (2025). The Ambiguous Role of HMGB1 Across the Hallmarks of Aging: A Narrative Review. <em>Clinical Interventions in Aging</em>. https://doi.org/10.2147/cia.s550572
Vancouver
Ning M, Liang Y, Zhang L, Wang F, He L. The Ambiguous Role of HMGB1 Across the Hallmarks of Aging: A Narrative Review. Clinical Interventions in Aging. 2025. doi:10.2147/cia.s550572.
BibTeX
@article{manru2025TheAmb,
title = {The Ambiguous Role of HMGB1 Across the Hallmarks of Aging: A Narrative Review},
author = {Manru Ning and Yihuai Liang and Liu Zhang and Feifei Wang and Li He},
journal = {Clinical Interventions in Aging},
year = {2025},
doi = {10.2147/cia.s550572},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Antioxidants 2023
Open access · CC-BY
Aging Hallmarks and the Role of Oxidative Stress
International journal of molecular sciences 2025
Open access · OA
Rewinding the Clock: Emerging Pharmacological Strategies for Human Anti-Aging Therapy.
International journal of molecular sciences 2025
Open access · OA
Microgravity Therapy as Treatment for Decelerated Aging and Successful Longevity.
International Journal of Biological Sciences 2021
Open access · CC-BY
Role of mismatch repair in aging
Annual Review of Biochemistry 2016
Open access · OA
Cellular Homeostasis and Aging
Biogerontology 2025
Citation only